Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ulipristal acetate versus levonorgestrel-releasing intrauterine system for heavy menstrual bleeding
ISRCTN20426843Phase 3Completed
- Sponsor
- NHS Lothian
- Start
- Apr 2015
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
01
Overview
Phase 3, randomised, open-label trial of ulipristal and avatrombopag in hypermenorrhea and menstrual disorders (2 arms), sponsored by NHS Lothian. Primary endpoint: Menorrhagia Multi-Attribute Scale. Started Apr 2015; status: completed.
02
Drugs
ulipristalavatrombopag
03
Conditions
hypermenorrheamenstrual disorders
Beyond the preview
Go deeper on ISRCTN20426843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN20426843.